Clorox names Fabian Garcia CEO as Linda Rendle steps down
Clorox appointed Fabian Garcia CEO effective January 5, 2027. Linda Rendle leaves her CEO and board roles, and Matthew J. Shattock becomes independent chair.
- published on Newsmetry
- original source published
the same feed is available to bots and dashboards through the api. connect the api →
what happened
Clorox appointed Fabian Garcia as chief executive and a director effective January 5, 2027, according to TradingView, which cited documents filed with the SEC. Linda Rendle is stepping down from her CEO and board roles and will move into a senior advisory role running through April 2, 2027.
Garcia has led the personal care business group at Unilever since 2022. He previously served as CEO of Revlon and held positions at Colgate-Palmolive and Procter & Gamble. Under his offer letter, his base salary is $100,000, his target annual bonus is $2 million, and his sign-on RSU award is $11 million.
Matthew J. Shattock, currently lead independent director, will become independent chair, with a $225,000 chair retainer on top of the standard director pay.
why it matters
A leadership change at a large consumer goods company rarely moves the market on its own, but Clorox investors will watch how the new CEO shapes strategy. The filing does not disclose the reason for Rendle's departure.
market impact
Clorox shares: the leadership change may shift investor expectations about the company's strategy
tags
instruments
sources
- Clorox appoints Fabian Garcia CEO as Linda Rendle steps down — TradingView, 29 October 2026 at 11:13 UTC
- Clorox appoints Fabian Garcia as CEO — Seeking Alpha, 29 October 2026 at 11:21 UTC
prepared by the newsmetry newsroom with ai assistance from the sources listed below. not investment advice.
alerts on your topics, the morning digest and the api — in your account.
get stories in real time ↗